ELAB - PMGC Holdings Inc.
1.05
0.040 3.810%
Share volume: 136,230
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$1.01
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 03-28-2025 | 05-14-2025 | 11-14-2025 | |
| Total revenue | 614.563 K | 605.529 K | 527.478 K | -1.748 M | 0.000 | 571.896 K | |
| Cost of revenue | 168.911 K | 166.275 K | 133.577 K | -468.763 K | 0.000 | 520.497 K | |
| Gross profit | 445.652 K | 439.254 K | 393.901 K | -1.279 M | 0.000 | 78.030 K | |
| -1.44% | -10.33% | -424.65% | 100.00% | inf% | |||
| Operating expenses | 1.162 M | 874.484 K | 898.957 K | -1.175 M | 507.932 K | 1.131 M | |
| Selling general and admin | 1.059 M | 822.099 K | 803.697 K | -1.029 M | 475.499 K | 1.116 M | |
| Research and development | 103.194 K | 52.385 K | 95.260 K | -146.185 K | 32.433 K | 15.000 K | |
| Total expenses | 2.129 M | 1.848 M | 1.313 M | -1.631 M | 1.072 M | 1.960 M | |
| -13.20% | -28.94% | -224.26% | 165.70% | 82.90% | |||
| Operating income | -1.683 M | -1.409 M | -919.837 K | 354.191 K | -1.072 M | -2.199 M | |
| Ebit | -1.374 M | -1.382 M | -855.238 K | 317.163 K | -1.539 M | -2.453 M | |
| Pretax income | -1.398 M | -1.413 M | -1.503 M | 297.287 K | -1.520 M | -2.330 M | |
| 1.07% | 6.42% | -119.77% | -611.43% | 53.25% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.397 M | -1.412 M | -1.501 M | -1.935 M | -1.548 M | -2.308 M | |
| -1.09% | -6.28% | -28.87% | 19.99% | -49.11% |